Cargando…
Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis
BACKGROUND: Angiopoietin-like proteins (ANGPTLs) are closely related to insulin resistance and lipid metabolism, and may be a key in metabolic syndrome. Non-alcoholic fatty liver disease (NAFLD) (newly named metabolic-associated fatty liver disease (MAFLD)) is based on metabolic dysfunction. There m...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152125/ https://www.ncbi.nlm.nih.gov/pubmed/34034750 http://dx.doi.org/10.1186/s12944-021-01481-1 |
_version_ | 1783698540245024768 |
---|---|
author | Ke, Yani Liu, Shan Zhang, Zheyuan Hu, Jie |
author_facet | Ke, Yani Liu, Shan Zhang, Zheyuan Hu, Jie |
author_sort | Ke, Yani |
collection | PubMed |
description | BACKGROUND: Angiopoietin-like proteins (ANGPTLs) are closely related to insulin resistance and lipid metabolism, and may be a key in metabolic syndrome. Non-alcoholic fatty liver disease (NAFLD) (newly named metabolic-associated fatty liver disease (MAFLD)) is based on metabolic dysfunction. There may be some correlation between ANGPTLs and MAFLD, but the specific correlation is unclear. This study aims to explore the predictive role of ANGPTLs in MAFLD and its progression. METHODS: Seven databases (PubMed, EMBASE, Cochrane Library, CNKI, WANFANG, CBM and Clinicaltrials.gov) were searched with free terms and MeSH terms. The random-effects model was used to pool the data, and Standardized Mean Difference (SMD) and 95% confidence intervals (CI) were taken as the overall outcome. No language restrictions existed in the article selection. RevMan 5.3, Stata 16 and MetaXL software were applied to analyse the data and the GRADE system was utilized to assess the certainty of evidence. RESULTS: After reviewing 823 related articles, 13 studies (854 cases and 610 controls) met the inclusion criteria, and contributed to this meta-analysis. The results showed that circulating ANGPTL8 level was significantly elevated in the MAFLD group than in the healthy control group (SMD = 0.97 pg/mL, 95%CI: 0.77, 1.18). Conversely, there was no significant difference in the ANGPTL4 (SMD = 0.11 ng/mL, 95%CI: − 0.32, 0.54) and ANGPTL3 (SMD = − 0.95 ng/mL, 95%CI: − 4.38, 2.48) between the two groups. Subgroup analysis showed that: 1) the MAFLD group had significantly higher ANGPTL8 levels than the healthy control group in Asian and other races; 2) the ANGPTL8 levels in Body Mass Index (BMI) > 25 kg/m(2) patients with MAFLD were higher than those in the healthy control group; 3) the higher ANGPTL8 levels were observed in moderate to severe MAFLD group than the healthy control group. Meta-regression demonstrated that BMI might effectively explain the high heterogeneity. No significant publication bias existed (P > 0.05). The certainty of evidence was assessed as very low by the GRADE system. CONCLUSIONS: The ANGPTLs may be related to MAFLD. The increased ANGPTL8 level may be positively correlated with different situations of MAFLD, which may act as a potential indicator to monitor the development trends. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-021-01481-1. |
format | Online Article Text |
id | pubmed-8152125 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81521252021-05-26 Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis Ke, Yani Liu, Shan Zhang, Zheyuan Hu, Jie Lipids Health Dis Review BACKGROUND: Angiopoietin-like proteins (ANGPTLs) are closely related to insulin resistance and lipid metabolism, and may be a key in metabolic syndrome. Non-alcoholic fatty liver disease (NAFLD) (newly named metabolic-associated fatty liver disease (MAFLD)) is based on metabolic dysfunction. There may be some correlation between ANGPTLs and MAFLD, but the specific correlation is unclear. This study aims to explore the predictive role of ANGPTLs in MAFLD and its progression. METHODS: Seven databases (PubMed, EMBASE, Cochrane Library, CNKI, WANFANG, CBM and Clinicaltrials.gov) were searched with free terms and MeSH terms. The random-effects model was used to pool the data, and Standardized Mean Difference (SMD) and 95% confidence intervals (CI) were taken as the overall outcome. No language restrictions existed in the article selection. RevMan 5.3, Stata 16 and MetaXL software were applied to analyse the data and the GRADE system was utilized to assess the certainty of evidence. RESULTS: After reviewing 823 related articles, 13 studies (854 cases and 610 controls) met the inclusion criteria, and contributed to this meta-analysis. The results showed that circulating ANGPTL8 level was significantly elevated in the MAFLD group than in the healthy control group (SMD = 0.97 pg/mL, 95%CI: 0.77, 1.18). Conversely, there was no significant difference in the ANGPTL4 (SMD = 0.11 ng/mL, 95%CI: − 0.32, 0.54) and ANGPTL3 (SMD = − 0.95 ng/mL, 95%CI: − 4.38, 2.48) between the two groups. Subgroup analysis showed that: 1) the MAFLD group had significantly higher ANGPTL8 levels than the healthy control group in Asian and other races; 2) the ANGPTL8 levels in Body Mass Index (BMI) > 25 kg/m(2) patients with MAFLD were higher than those in the healthy control group; 3) the higher ANGPTL8 levels were observed in moderate to severe MAFLD group than the healthy control group. Meta-regression demonstrated that BMI might effectively explain the high heterogeneity. No significant publication bias existed (P > 0.05). The certainty of evidence was assessed as very low by the GRADE system. CONCLUSIONS: The ANGPTLs may be related to MAFLD. The increased ANGPTL8 level may be positively correlated with different situations of MAFLD, which may act as a potential indicator to monitor the development trends. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-021-01481-1. BioMed Central 2021-05-25 /pmc/articles/PMC8152125/ /pubmed/34034750 http://dx.doi.org/10.1186/s12944-021-01481-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Ke, Yani Liu, Shan Zhang, Zheyuan Hu, Jie Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis |
title | Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis |
title_full | Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis |
title_fullStr | Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis |
title_full_unstemmed | Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis |
title_short | Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis |
title_sort | circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152125/ https://www.ncbi.nlm.nih.gov/pubmed/34034750 http://dx.doi.org/10.1186/s12944-021-01481-1 |
work_keys_str_mv | AT keyani circulatingangiopoietinlikeproteinsinmetabolicassociatedfattyliverdiseaseasystematicreviewandmetaanalysis AT liushan circulatingangiopoietinlikeproteinsinmetabolicassociatedfattyliverdiseaseasystematicreviewandmetaanalysis AT zhangzheyuan circulatingangiopoietinlikeproteinsinmetabolicassociatedfattyliverdiseaseasystematicreviewandmetaanalysis AT hujie circulatingangiopoietinlikeproteinsinmetabolicassociatedfattyliverdiseaseasystematicreviewandmetaanalysis |